AUGMENTIN- amoxicillin and clavulanate potassium powder, for suspension AUGMENTIN- amoxicillin and clavulanate potassium tablet

Nchi: Marekani

Lugha: Kiingereza

Chanzo: NLM (National Library of Medicine)

Viambatanisho vya kazi:

AMOXICILLIN (UNII: 804826J2HU) (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9), CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8) (CLAVULANIC ACID - UNII:23521W1S24)

Inapatikana kutoka:

Neopharma Inc

Njia ya uendeshaji:

ORAL

Dawa ya aina:

PRESCRIPTION DRUG

Matibabu dalili:

To reduce the development of drug‑resistant bacteria and maintain the effectiveness of AUGMENTIN (amoxicillin/clavulanate potassium) and other antibacterial drugs, AUGMENTIN should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. AUGMENTIN®  is a combination penicillin-class antibacterial and beta-lactamase inhibitor indicated in the treatment of infections due to susceptible isolates of the designated bacteria in the conditions listed below*:  caused by beta‑lactamase–producing isolates of Haemophilus influenzae and Moraxella catarrhalis .  caused by beta‑lactamase–producing isolates of H. influenzae and M. catarrhalis .  caused by beta‑lactamase–producing isolates of H. influenzae and M. cat

Bidhaa muhtasari:

Tablets: 250 mg/125 mg Tablets : Each white oval film-coated tablet, debossed with AUGMENTIN on one side and 250/125 on the other side, contains 250 mg amoxicillin as the trihydrate and 125 mg clavulanic acid as the potassium salt. NDC 72508-018-30               bottles of 30 NDC 72508-018-78               Unit Dose (10x10) 100 tablets 500 mg/125 mg Tablets : Each white oval film-coated tablet, debossed with AUGMENTIN on one side and 500/125 on the other side, contains 500 mg amoxicillin as the trihydrate and 125 mg clavulanic acid as the potassium salt. NDC 72508-006-14               bottles of 20 NDC 72508-006-78               Unit Dose (10x10) 100 tablets 875 mg/125 mg Tablets : Each scored white capsule‑shaped tablet, debossed with AUGMENTIN 875 on one side and scored on the other side, contains 875 mg amoxicillin as the trihydrate and 125 mg clavulanic acid as the potassium salt. NDC 72508-021-14               bottles of 20 NDC 72508-021-78               Unit Dose (10x10) 100 tablets Powder for Oral Suspension : 125 mg/31.25 mg per 5 mL : Banana-flavored powder for oral suspension (each 5 mL of reconstituted suspension contains 125 mg amoxicillin and 31.25 mg of clavulanic acid as the potassium salt). NDC 72508-012-01               75 mL bottle NDC 72508-012-03               100 mL bottle NDC 72508-012-05               150 mL bottle 200 mg/28.5 mg per 5 mL : Orange-flavored powder for oral suspension (each 5 mL of reconstituted suspension contains 200 mg amoxicillin and 28.5 mg of clavulanic acid as the potassium salt). NDC 72508-013-50               50 mL bottle NDC 72508-013-51               75 mL bottle NDC 72508-013-52               100 mL bottle 250 mg/62.5 mg per 5 mL : Orange-flavored powder for oral suspension (each 5 mL of reconstituted suspension contains 250 mg amoxicillin and 62.5 mg of clavulanic acid as the potassium salt). NDC 72508-004-07               75 mL bottle NDC 72508-004-10               100 mL bottle NDC 72508-004-15               150 mL bottle 400 mg/57 mg per 5 mL Orange-flavored powder for oral suspension (each 5 mL of reconstituted suspension contains 400 mg amoxicillin and 57.0 mg of clavulanic acid as the potassium salt). NDC 72508-008-50               50 mL bottle NDC 72508-008-51               75 mL bottle NDC 72508-008-52               100 mL bottle Chewable Tablets : 125 mg/31.25 mg Chewable Tablets : Each mottled yellow, round, lemon-lime-flavored tablet, debossed with BMP 189, contains 125 mg amoxicillin and 31.25 mg clavulanic acid as the potassium salt. NDC 72508-014-31               carton of 30 (5x6) tablets 200 mg/28.5 mg Chewable Tablets : Each mottled pink, round, biconvex, cherry-banana-flavored tablet, debossed with AUGMENTIN 200, contains 200 mg amoxicillin and 28.5 mg clavulanic acid as the potassium salt. NDC 72508-015-14               carton of 20 tablets 250 mg/62.5 mg Chewable Tablets : Each mottled yellow, round, lemon-lime-flavored tablet, debossed with BMP 190, contains 250 mg amoxicillin and 62.5 mg clavulanic acid as the potassium salt. NDC 72508-016-31               carton of 30 (5x6) tablets 400 mg/57 mg Chewable Tablets : Each mottled pink, round, biconvex, cherry-banana-flavored tablet, debossed with AUGMENTIN 400, contains 400 mg amoxicillin and 57.0 mg clavulanic acid as the potassium salt. NDC 72508-017-14   carton of 20 tablets Dispense in original container. Store tablets and dry powder at or below 25°C (77°F). Store reconstituted suspension under refrigeration. Discard unused suspension after 10 days. Keep out of the reach of children.

Idhini hali ya:

New Drug Application

Tabia za bidhaa

AUGMENTIN- AMOXICILLIN AND CLAVULANATE POTASSIUM POWDER, FOR
SUSPENSION
AUGMENTIN- AMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, FILM COATED
NEOPHARMA INC
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE
AUGMENTIN SAFELY AND
EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR AUGMENTIN.
AUGMENTIN®(AMOXICILLIN/CLAVULANATE POTASSIUM) TABLETS, POWDER FOR
ORAL SUSPENSION, AND
CHEWABLE TABLETS INITIAL U.S. APPROVAL: 1984
TO REDUCE THE DEVELOPMENT OF DRUG-RESISTANT BACTERIA AND MAINTAIN THE
EFFECTIVENESS OF
AUGMENTIN AND OTHER ANTIBACTERIAL DRUGS, AUGMENTIN SHOULD BE USED ONLY
TO TREAT
INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY
BACTERIA.
INDICATIONS AND USAGE
AUGMENTIN is a combination penicillin-class antibacterial and
beta‑lactamase inhibitor indicated for
treatment of the following:
Lower respiratory tract infections (1.1)
Acute bacterial otitis media (1.2)
Sinusitis (1.3)
Skin and skin structure infections (1.4)
Urinary tract infections (1.5)
DOSAGE AND ADMINISTRATION
· Adults and Pediatric Patients > 40 kg: 500 or 875 mg every 12 hours
or 250 or 500 mg every 8 hours.
(2.1, 2.2)
· Pediatric patients aged 12 weeks (3 months) and older: 25 to 45
mg/kg/day every 12 hours or 20 to 40
mg/kg/day every 8 hours, up to the adult dose. (2.2)
· Neonates and infants < 12 weeks of age: 30 mg/kg/day divided every
12 hours, based on the
amoxicillin component. Use of the 125 mg/5 mL oral suspension is
recommended. (2.2)
DOSAGE FORMS AND STRENGTHS
Formulations and amoxicillin/clavulanate content are:
Tablets: 250 mg/125 mg, 500 mg/125 mg, 875 mg/125 mg; 875 mg/125 mg
tablets are scored. (3)
Powder for Oral Suspension: 125 mg/31.25 mg per 5 mL, 200 mg/28.5 mg
per 5 mL, 250 mg/62.5 mg per
5 mL, 400 mg/57 mg per 5 mL (3)
Chewable Tablets: 125 mg/31.25 mg, 200 mg/28.5 mg, 250 mg/62.5 mg, 400
mg/57 mg (3)
CONTRAINDICATIONS
· History of a serious hypersensitivity reaction (e.g., anaphylaxis
or Stevens-Johnson syndrome) to
AUGMENTIN or to other be